Abstract:The seven canonical members of transient receptor potential (TRPC) proteins form cation channels that evoke membrane depolarization and intracellular calcium concentration ([Ca 2+ ] i ) rise, which are not only important for regulating cell function but their deregulation can also lead to cell damage. Recent studies have implicated complex roles of TRPC channels in neurodegenerative diseases including ischemic stroke. Brain ischemia reduces oxygen and glucose supply to neurons, i.e., Oxygen and Glucose Deprivation (OGD), resulting in [Ca 2+ ] i elevation, ion dyshomeostasis, and excitotoxicity, which are also common in many forms of neurodegenerative diseases. Although ionotropic glutamate receptors, e.g., N -methyl- D -aspartate receptors, are well established to play roles in excitotoxicity, the contribution of metabotropic glutamate receptors and their downstream effectors, i.e., TRPC channels, should not be neglected. Here, we summarize the current findings about contributions of TRPC channels in neurodegenerative diseases, with a focus on OGD-induced neuronal death and rodent models of cerebral ischemia/reperfusion. TRPC channels play both detrimental and protective roles to neurodegeneration depending on the TRPC subtype and specific pathological conditions involved. When illustrated the mechanisms by which TRPC channels are involved in neuronal survival or death seem differ greatly, implicating diverse and complex regulation. We provide our own data showing that TRPC1/C4/C5, especially TRPC4, may be generally detrimental in OGD and cerebral ischemia/reperfusion. We propose that although TRPC channels significantly contribute to ischemic neuronal death, detailed mechanisms and specific roles of TRPC subtypes in brain injury at different stages of ischemia/reperfusion and in different brain regions need to be carefully and systematically investigated.

TRP channels: Role in neurodegenerative diseases and therapeutic targets

Roles of TRP Channels in Neurological Diseases

Transient receptor potential channels as an emerging target for the treatment of Alzheimer's disease: Unravelling the potential of pharmacological interventions

TRP (transient receptor potential) ion channel family: structures, biological functions and therapeutic interventions for diseases

TRPV4 Channel in Neurological Disease: from Molecular Mechanisms to Therapeutic Potential

Exploring therapeutic potential: Targeting TRPM7 in neurodegenerative diseases

Targeting Transient Receptor Potential Canonical Channels for Diseases of the Nervous System.

Targeting TRP channels: recent advances in structure, ligand binding, and molecular mechanisms

Transient receptor proteins illuminated: current views on TRPs and disease

The Pivotal Role of TRP Channels in Homeostasis and Diseases throughout the Gastrointestinal Tract

TRP channels: an overview

Transient Receptor Potential Channels in the Healthy and Diseased Blood-Brain Barrier

Contribution of TRPC Channels in Neuronal Excitotoxicity Associated With Neurodegenerative Disease and Ischemic Stroke

TRPM7 in neurodevelopment and therapeutic prospects for neurodegenerative disease

TRP channel function in platelets and megakaryocytes: basic mechanisms and pathophysiological impact

Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel

Canonical Transient Receptor Potential (TRPC) Channels in Cardiovascular Pathology and their Modulators

TRPC Channels and Programmed Cell Death

Pathological function of transient receptor potential canonical 6 channel in key central nervous system diseases:its prospects as drug targets

TRP channels: molecular diversity and physiological function

Research progress on transient receptor potential melastatin 2 channel in nervous system diseases.